Article ; Online: CoViD-19 e malattie croniche: conoscenze attuali, passi futuri e il progetto MaCroScopio.
2020 Volume 111, Issue 4, Page(s) 198–201
Abstract: Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease ... among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact ... on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has ...
Title translation | CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project. |
---|---|
Abstract | Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease. Epidemiological data and studies performed show different rates of chronic diseases and multimorbidity among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has taken measures to extend the therapeutic plans and monitoring registers; hopefully, therapeutic plans for antidiabetics, drugs for respiratory diseases and oral anticoagulant drugs will be abolished since they do not offer any additional advantage in terms of appropriateness and traceability of outcomes. The MaCroScopio project (Observatory on Chronic Diseases), regarding the CoViD-19 emergency, has started a new research path to foster the integration of the administrative data flows with the CoViD-19 Registers for planning and research purposes in the context of chronicity, as well as to evaluate the economic and organizational impact of the pandemic. |
MeSH term(s) | Anticoagulants/therapeutic use ; Betacoronavirus ; COVID-19 ; Chronic Disease ; Comorbidity ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Data Collection ; Health Knowledge, Attitudes, Practice ; Humans ; Hypoglycemic Agents/therapeutic use ; Pandemics ; Patient Care Planning ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Respiratory Tract Diseases ; Risk Factors ; SARS-CoV-2 ; Vulnerable Populations |
Chemical Substances | Anticoagulants ; Hypoglycemic Agents |
Keywords | covid19 |
Language | Italian |
Publishing date | 2020-04-21 |
Publishing country | Italy |
Document type | Journal Article |
ZDB-ID | 138266-4 |
ISSN | 2038-1840 ; 0034-1193 |
ISSN (online) | 2038-1840 |
ISSN | 0034-1193 |
DOI | 10.1701/3347.33180 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 193: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.